Nanomics Biotechnology Co., Ltd.

Nanomics Biotechnology Co., Ltd. (珞米生命科技) is presented here as a commercial biotechnology entity. The only evidence supplied for this dossier is an unrelated news article about Marvell's CXL memory expansion controllers, which contains no information about Nanomics Biotechnology. As a result, no verifiable facts about the company's founding, headquarters, ownership, products, leadership, or market position can be confirmed from the available material. Because the name suggests a biotechnology venture, the most plausible taxonomy placement would be in health care or life sciences, but this is an inference from the name alone and is not supported by evidence. No official website, Wikipedia entry, or reliable public source was provided. This entry should be treated as provisional. It is retained so that the brand record exists, but it requires review and additional sourcing before any substantive claims are added. No products, campaigns, executives, milestones, or financial details are asserted here, in keeping with the requirement not to fabricate information.

• 2026

  US ITC issues partial final determination in Section 337 investigation with Nanomics Biotechnology as default respondent

  On October 13, 2026, the U.S. International Trade Commission announced a partial final determination in Section 337 investigation No. 337-TA-1508, concerning certain systems, devices, software, compositions, chemicals, and laboratory supplies for studying proteins. The Commission declined to review the administrative law judge's September 16, 2026 initial determination (No. 7), under which the sole named respondent, Nanomics Biotechnology Co., Ltd. of Hangzhou, Zhejiang, China, was found in default, and which recommended remedies of a general exclusion order and a cease-and-desist order. Interested parties, government agencies, and individuals may submit comments of no more than 15 pages on the recommended remedies, the public interest, and the bond by October 30, 2026.

  Source

Read more

1. 1Marvell将于2026年10月推出新一代 CXL 内存扩展控制器样片_新浪科技_新浪网finance.sina.com.cn
2. 2US ITC issues partial final determination in Section 337 investigation with Nanomics Biotechnology as default respondent163.com